XML 81 R70.htm IDEA: XBRL DOCUMENT v3.24.2
Equity - Narrative (Details)
 3 Months Ended 6 Months Ended
Dec. 31, 2023
USD ($)
shares
Jun. 30, 2024
USD ($)
property
shares
Jun. 30, 2024
USD ($)
property
$ / shares
shares
Jun. 30, 2023
USD ($)
shares
Aug. 31, 2022
shares
Equity [Line Items]          
Authorized amount (in shares) | shares         10,000,000
Common shares repurchased (in shares) | shares     0 0  
Shares remaining available for repurchase (in shares) | shares   6,874,241 6,874,241    
Unsettled repurchases   $ 0 $ 0    
Series C cumulative convertible preferred, shares outstanding (in shares) | shares 1,935,400 1,935,400 1,935,400    
Series C cumulative convertible preferred, liquidation preference $ 96,770,000 $ 96,770,000 $ 96,770,000    
OP unit equivalent in common shares     1.13    
Partners capital account, shares issued for units redeemed | shares 822,627     4,886  
Partners' capital account, exchanges and conversions $ 7,800,000     $ 25,000  
Exchange ratio of partner units (in shares) 1.13        
Purchase of noncontrolling interest in consolidated joint venture   22,988,000 $ 27,898,000    
Additional Paid-in-Capital          
Equity [Line Items]          
Purchase of noncontrolling interest in consolidated joint venture   $ 20,447,000 $ 23,843,000    
Warehouse / Distribution Facility          
Equity [Line Items]          
Number of properties | property   2 2    
Purchase of remaining equity     $ 27,873,000    
Series C Cumulative Convertible Preferred Stock          
Equity [Line Items]          
Series C cumulative convertible preferred, shares outstanding (in shares) | shares   1,935,400 1,935,400    
Preferred stock, dividend per annum (in dollars per share) | $ / shares     $ 3.25    
Series C cumulative convertible preferred, liquidation preference   $ 96,770,000 $ 96,770,000    
Convertible preferred stock, conversion ratio (in shares) | shares   2.4339 2.4339    
Preferred stock conversion, threshold conversion price percentage (at least)   1.25 1.25    
Unvested share-based payment awards          
Equity [Line Items]          
Shares granted (in shares) | shares     50,505 46,440  
Grant date fair value     $ 450,000 $ 480,000  
At-The-Market Program          
Equity [Line Items]          
Sale of stock, authorized amount (up to)   $ 350,000,000 $ 350,000,000